Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anidulafungin for Azole-Refractory Mucosal Candidiasis
NCT00041704Phase 2Completed
- Sponsor
- Pfizer
- Start
- Aug 2002
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of anidulafungin in mucosal candidiasis, sponsored by Pfizer. Started Aug 2002; status: completed.
02
Drugs
anidulafungin
03
Conditions
mucosal candidiasis
Beyond the preview
Go deeper on NCT00041704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041704.